Impact of Levetiracetam Treatment on 5-Aminolevulinic Acid Fluorescence Expression in IDH1 Wild-Type Glioblastoma

SIMPLE SUMMARY: The amino acid 5-aminolevulinic acid (5-ALA) is the benchmark regarding intraoperative imaging tools for glioblastoma (GB) surgery, and is known to facilitate the extent of resection, which results in an enhanced 6 month progression-free survival rate. Recent in vitro studies suggest...

Descripción completa

Detalles Bibliográficos
Autores principales: Wach, Johannes, Güresir, Ági, Hamed, Motaz, Vatter, Hartmut, Herrlinger, Ulrich, Güresir, Erdem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099986/
https://www.ncbi.nlm.nih.gov/pubmed/35565263
http://dx.doi.org/10.3390/cancers14092134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099986/
https://www.ncbi.nlm.nih.gov/pubmed/35565263
http://dx.doi.org/10.3390/cancers14092134

Ejemplares similares